Search Ontology:
ChEBI
fluvoxamine
- Term ID
- CHEBI:5138
- Synonyms
-
- (1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-(2-aminoethyl)oxime
- 2-{[(E)-{5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino]oxy}ethan-1-amine
- fluvoxamina
- fluvoxamine
- fluvoxaminum
- O-(2-aminoethyl)-N-{(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}hydroxylamine
- Definition
- An oxime O-ether that is benzene substituted by a (1E)-N-(2-aminoethoxy)-5-methoxypentanimidoyl group at position 1 and a trifluoromethyl group at position 4. It is a selective serotonin reuptake inhibitor that is used for the treatment of obsessive-compulsive disorder.
- References
-
- beilstein:5583954
- cas:54739-18-3
- chemspider:4481878
- drugbank:DB00176
- drugcentral:1230
- hmdb:HMDB0014322
- kegg.compound:C07571
- kegg.drug:D07984
- metacyc.compound:CPD-20520
- patent:NL7503310
- patent:US4085225
- pdb-ccd:FVX
- pubmed:10456487
- pubmed:11825104
- pubmed:12107854
- pubmed:15686112
- pubmed:16316311
- pubmed:18976545
- pubmed:20025739
- pubmed:20573265
- pubmed:22859721
- pubmed:24121440
- pubmed:29379174
- pubmed:30690950
- pubmed:30734885
- pubmed:31807102
- pubmed:31807753
- pubmed:32618683
- pubmed:32672818
- pubmed:33180097
- pubmed:33392622
- pubmed:7988100
- pubmed:9164424
- wikipedia.en:Fluvoxamine
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from fluvoxamine
Phenotype where environments contain fluvoxamine
Phenotype modified by environments containing fluvoxamine
Phenotype affecting fluvoxamine
Human Disease Model